Lifeboat Foundation

High-fidelity touch has the potential to significantly expand the scope of what we expect from computing devices, making new remote sensory experiences possible. The research on these advancements, led by a pair of researchers from the J. Mike Walker Department of Mechanical Engineering at Texas A&M University, could help touchscreens simulate virtual shapes.

Dr. Cynthia Hipwell is studying friction at the finger-device level, while Dr. Jonathan Felts is researching friction in the interaction between single skin cells and the glass of the touchscreen interface. The two are bringing together their respective areas of expertise to apply friction principles at the microscopic level to finger-device interaction mechanics.

Continue reading “Temperature variation could help new touchscreen technology simulate virtual shapes” »

Elon Musk’s Starlink internet project continues to move forward, launch by launch.

SpaceX launched another 47 internet-beaming satellites from Kennedy Space Center in Florida on Thursday morning.

Continue reading “Watch a SpaceX rocket fly for a record 11th time” »

Hackers who penetrated the network of the American chip manufacturer NVIDIA have leaked DLSS source code on the Internet.

Nearly 75% of network-connected infusion pumps contain security vulnerabilities.

Scientists from Roswell Park Comprehensive Cancer Center have shed light on a different way of overcoming mechanisms of resistance to specific therapeutic agents used to treat cancer. In a new article published March 1 in the journal Cell Reports, the researchers propose a new approach to cancer treatment based on the way different cancer cells divide.

A collaborative team led by Agnieszka Witkiewicz, MD, Professor of Oncology, and Erik Knudsen, Ph.D., Professor of Oncology and Chair of Molecular and Cellular Biology, from Roswell Park investigated over 500 cell lines from a multitude of cancer types, as well as preclinical tumor models. The researchers then analyzed cancer cells based on their dependency for CDK and CCN, two genes that drive the cell cycle and determine how often a cancer cell divides.

“We found that the way cancer cells divide is highly varied, and that diversity represents a tremendous challenge for some widely used cancer therapies because it often contributes to treatment resistance,” says Dr. Witkiewicz, the study’s senior author. “However, with a better understanding of these heterogenous features of cancer cell division, different therapies could be deployed in a more precise and effective fashion.”